Bionano Genomics, Inc. — Director's Dealing 2020

Feb 20, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Bionano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2020-02-18

Reporting Person: Adams Heather (Chief Administrative Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2625	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$1.30	2027-05-01	Common Stock (116)		Direct
Stock Option (right to buy)	$1.30	2027-05-01	Common Stock (3738)		Direct
Stock Option (right to buy)	$7.77	2028-09-30	Common Stock (41410)		Direct
Stock Option (right to buy)	$4.25	2029-02-28	Common Stock (30000)		Direct

Footnotes

F1: 25% of the shares vested on April 3, 2018, and the remaining shares vest in 12 equal quarterly installments thereafter.

F2: 25% of the shares vested on October 1, 2018, and the remaining shares vest in 36 equal monthly installments thereafter.

F3: The shares vest in 48 equal monthly installments from March 1, 2019 (the "Grant Date").